Peripheral blood mononuclear cell microchimerism in Turkish female patients with systemic sclerosis

REFERENCES

• LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classifi-cation, subsets and pathogenesis. J Rheumatol. 1988;15(2):202–5.
   Google Scholar
• Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009;360(19):1989–2003.
   PubMed Web of Science ®Google Scholar
• Ruzek MC, Jha S, Ledbetter S, Richards SM, Garman RD. A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease. Arthritis Rheum. 2004;50(4):1319–31.
   Google Scholar
• Jimenez SA. Artlett CM Microchimerism and systemic sclerosis. Curr Opin Rheumatol. 2005;17(1):86–90.
   PubMedGoogle Scholar
• Lee ES, Bou-Gharios G, Seppanen E, Khosrotehrani K, Fisk NM. Fetal stem cell microchimerism: natural-born healers or killers? Mol Hum Reprod. 2010;16(11):869–78.
   PubMedGoogle Scholar
• Sarkar K, Miller FW. Possible roles and determinants of micro-chimerism in autoimmune and other disorders. Autoimmun Rev. 2004;3(6):454–63.
   PubMedGoogle Scholar
• Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA. 1996; 93(2):705–8.
   Google Scholar
• Lo YM, Patel P, Sampietro M, Gillmer MD, Fleming KA, Wainscoat JS. Detection of single-copy fetal DNA sequence from maternal blood. Lancet. 1990;335(8703):1463–4.
   PubMedGoogle Scholar
• Nelson JL. Maternal-fetal immunology and autoimmune disease: is some autoimmune disease auto-alloimmune or allo-autoim-mune? Arthritis Rheum. 1996;39(2):191–4.
   PubMed Web of Science ®Google Scholar
• Artlett CM. Microchimerism in health and disease. Curr Mol Med. 2002;2(6):525–35.
   PubMedGoogle Scholar
• Lambert NC, Lo YM, Erickson TD, Tylee TS, Guthrie KA, Furst DE, et al. Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answer. Blood. 2002;100(8):2845–51.
   PubMed Web of Science ®Google Scholar
• Subcommittee for Scleroderma Criteria of the American Rheu-matism Association Diagnostic and Therapeutic Criteria Com-mittee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23(5):581–90.
   PubMedGoogle Scholar
• McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, et al. ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension. A report of the American College of Cardiology Foundation Task Force on Expert Consensus Docu-ment and the American Heart Association. Circulation. 2009; 119:2250–94.
   Google Scholar
• Khanna D, Brown KK, Clements PJ, Elashoff R, Furst DE, Goldin J, Seibold JR, Silver RM, Tashkin DP, Wells AU. Sys-temic sclerosis-associated interstitial lung disease proposed rec-ommendations for future randomized clinical trials. Clin Exp Rheumatol. 2010;28(Suppl. 58):555–62.
   Google Scholar
• Boueiz A, Mathai SC, Hummers LK, Hassoun PM. Cardiac complications of systemic sclerosis: recent progress in diagnosis. Curr Opin Rheumatol. 2010;22:696–703.
   PubMed Web of Science ®Google Scholar
• Clements PJ, Becvar R, Drosos AA, Ghattas L, Gabrielli A. Assessment of gastrointestinal involvement. Clin Exp Rheumatol. 2003;21(3 Suppl 29):515–8.
   Google Scholar
• Denton CP, Lapadula G, Mouhon L, Muller-Ladner U. Renal complications and scleroderma renal crisis. Rheumatology (Oxford). 2009;48\(Suppl 3):iii32–5.
   Google Scholar
• Medsger TA Jr, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W. Assessment of disease severity and prognosis. Clin Exp Rheumatol. 2003;21(Suppl 29):542–6.
   Google Scholar
• Shimada K, Murakami K, Shozu M, Segawa T, Sumitani H, Inoue M. Sex-determining region Y levels in maternal plasma: evaluation in abnormal pregnancy. J Obstet Gynaecol Res. 2004;30(2):148–54.
   PubMedGoogle Scholar
• Ponchel F, Toomes C, Bransfield K, Leong FT, Douglas SH, Field SL, et al. Real-time PCR based on SYBR-green I fluo-rescence: an alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletions. BMC Biotechnol. 2003;3:18.
   PubMed Web of Science ®Google Scholar
• Thomas MR, Williamson R, Craft I, Yazdani N, Rodeck CH. Y chromosome sequence DNA amplified from peripheral blood of women in early pregnancy. Lancet. 1994;343(8894):413–4.
   Google Scholar
• Schroder J, Tilikianen A, De la Chapelle A. Fetal leukocytes in the maternal circulation after delivery. Transplantation. 1974;17(4):346–54.
   Google Scholar
• Schroder J. Transplacental passage of blood cells. J Med Genet. 1975;12(3):230–42.
   PubMedGoogle Scholar
• Jiang S-P, Vacchio MS. Multiple mechanisms of peripheral T-cell tolerance to the fetal "allograft". J Immunol. 1998; 160(7):3086–90.
   PubMedGoogle Scholar
• Black CM, Stevens WM. Scleroderma. Rheum Dis Clin North Am. 1989;15(2):193–212.
   PubMedGoogle Scholar
• Artlett CM, Welsh KI, Black CM, Jimenez SA. Fetal-maternal HLA compatibility confers susceptibility to systemic sclerosis. Immunogenetics. 1997;47(1):17–22.
   PubMedGoogle Scholar
• Nelson JL, Furst DE, Maloney S, et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet. 1998;351(9102):559–62.
   PubMed Web of Science ®Google Scholar
• Artlett CM. Pathophysiology of fetal microchimeric cells. Clin Chim Acta. 2005;360(1-2):1–8.
   PubMedGoogle Scholar
• Gammill SH, Nelson JL. Naturally acquired microchimerism. Int J Dev Biol. 2010;54(2-3):531–43.
   PubMed Web of Science ®Google Scholar
• Artlett CM, Cox LA, Ramos RC, Dennis TN, Fortunato RA, Hummers LK, et al. Increased microchimeric CD4+ T-lympho-cytes in peripheral blood from women with systemic sclerosis. Clin Immunol. 2002;103(3 Pt 1):303–8.
   Google Scholar
• Sawaya HH, Jimenez SA, Artlett CM. Quantification of fetal microchimeric cells in clinically affected and unaffected skin of patients with systemic sclerosis. Rheumatology (Oxford). 2004;43(8):965–8.
   Google Scholar
• Artlett CM, Dito CG, Christner PJ. Methodology for detecting trace amounts of microchimeric DNA from peripheral murine white blood cells by real-time PCR. Biol Proced Online. 2003;5:103–7.
   Google Scholar
• Mosca M, Giuliano T, Curcio M, Doveri M, De Feo F, Tani C, et al. Comparison of real-time PCR and nested PCR for the detection of Y chromosome sequences in the peripheral blood mononuclear cells of patients with systemic sclerosis. Ann Rheum Dis. 2009;68(1):155–6.
   PubMedGoogle Scholar
• Mosca M, Curcio M, Lapi S, Valentini G, D'Angelo S, Rizzo G, et al. Correlations of Y chromosome microchimerism with dis-ease activity in patients with SLE: analysis of preliminary data. Ann Rheum Dis. 2003;62(7):651–4.
   Google Scholar
• Lambert NC, Erickson TD, Yan Z, Pang JM, Guthrie KA, Furst DE, et al. Quantification of maternal microchimerism by HLA-specific real-time polymerase chain reaction: studies of healthy women and women with scleroderma. Arthritis Rheum. 2004;50(3):906–14.
   PubMedGoogle Scholar
• Christner PJ, Artlett CM, Conway RF, Jimenez SA. Increased numbers of microchimeric cells of fetal origin are associated with dermal fibrosis in mice following injection of vinyl chloride. Arthritis Rheum. 2000;43(11):2598–605.
   PubMedGoogle Scholar
• Evans PC, Lambert N, Maloney S, Furst DE, Moore JM, Nelson JL. Long-term fetal microchimerism in peripheral blood mono-nuclear cell subsets in healthy women and women with sclero-derma. Blood. 1999;93(6):2033–7.
   PubMedGoogle Scholar
• Burastero SE, Galbiati S, Vassallo A, Sabbadini MG, Bellone M, Marchionni L, et al. Cellular microchimerism as a lifelong physiologic status in parous women. An immunologic basis for its amplification in patients with systemic sclerosis. Arthritis Rheum. 2003;48(4):1109–16.
   Google Scholar
• Selva-O'Callaghan A, Mijares-Boeckh-Behrens T, Prades EB, Solans-Laque R, Simeon-Aznar CP, Fonollosa-Pla V, et al. Lack of evidence of foetal microchimerism in female Spanish patients with systemic sclerosis. Lupus. 2003;12(1):15–20.
   Google Scholar